News

If you own the InfraCap MLP ETF (NYSEARCA:AMZA) for income, the question is simple: can the fund keep cutting those $0.34 monthly checks? AMZA pays a roughly 7.5% to 8% distribution yield from a concentrated, leveraged basket of energy midstream Master Limited Partnerships, and management just raised the monthly payout from $0.29 in 2025 to ... AMZA jumped 158% in two years, but the math behind those $0.34 checks is fragile

AMADY vs. SYM: Which Stock Is the Better Value Option?

The SonicShares Global Shipping ETF (NYSEARCA:BOAT) has become the cleanest way for income investors to play the Strait of Hormuz blockade, and the tape shows it. BOAT closed near $43, up about 37% year to date and roughly 75% over the past year, while throwing off a trailing yield in the 6.3% range. The question ... BOAT is soaring over the Strait of Hormuz blockade, but will it last?

Ford looks cheap with a 0.28 forward sales multiple, strong Q1 beat, higher guidance, and tariff relief- but challenges remain.

Qualcomm stock surged Monday and is on pace for its first record close since 2024 as enthusiasm around AI chips and data-center demand continues to build.

Novo Nordisk stock jumps 21% in a month after a Q1 beat and stronger GLP-1 demand, but pricing pressure and Eli Lilly rivalry still cloud its 2026 outlook.

Circle Internet Group (NYSE:CRCL) reported first-quarter revenue that fell short of analyst expectations but topped earnings estimates, as the stablecoin issuer pointed to explosive growth in USDC transaction activity and launched a new suite of services targeting artificial intelligence...

Alibaba Group Holding (BABA) is back in focus as a cluster of analyst upgrades intersects with fresh AI product rollouts, including warehouse robots and conversational shopping tools embedded across its core ecommerce platforms. See our latest analysis for Alibaba Group Holding. Alibaba’s recent AI launches and analyst upgrades come after a 10.0% 1 month share price return and a 5.1% gain over the past week. However, the stock is still down 10.1% year to date, while the 1 year total...

Eli Lilly CFO Lucas Montrace joins Ashley Mastronardi on NYSE Live to discuss his YOY Revenue Beat

CVS Health (CVS) is back in focus after first quarter 2026 results and raised full year guidance, with management highlighting broad based strength across Aetna, Health Services, and Pharmacy & Consumer Wellness. See our latest analysis for CVS Health. After the earnings beat and guidance raise, the share price has climbed to US$90.55, with a 1 month share price return of 14.14% and a 1 year total shareholder return of 44.83%. This suggests momentum has picked up recently compared with longer...

In early May 2026, Shopify reported first-quarter results showing revenue of US$3.17 billion and sales of US$2.42 billion, while narrowing its net loss to US$581 million and modestly improving loss per share from continuing operations. Management also outlined expectations for high-twenties percentage revenue growth in the second quarter and highlighted rapid uptake of its AI-powered tools, which are driving higher store traffic and order volumes across its merchant base. We’ll now examine...

Tesla Bulls Get Fresh Catalyst as Robotaxi Rollout Expands Nationwide

Dell Technologies has been one of the highest-flying stocks in the index this year, but it might be time to take some chips off the table, according to UBS. The investment bank downgraded Dell shares to Neutral from Buy in a research note over the weekend, although it lifted its price target to $243 from $167. Dell’s server business is in excellent shape, UBS argued, but demand from artificial-intelligence companies is already baked into the stock price.

BP (NYSE:BP) just received a rare same-day double upgrade from Wall Street. Argus moved BP stock to Buy from Hold, and RBC Capital lifted the stock to Outperform from Sector Perform with a 700 GBp price target. The simultaneous bullish shift signals coordinated conviction that BP’s recovery story is finally taking shape under new CEO ... BP Just Got a Wall Street Double Upgrade: Argus, RBC Both Turn Bullish on Recovery Story

Both Comcast (NASDAQ: CMCSA) and Netflix (NASDAQ: NFLX) have taken hits over the past month, and retirement-focused investors are wondering which one belongs in the portfolio right now. Both stocks are bruised, both are buying back shares, and both are in the Communication Services sector. But the cases diverge sharply on price, payout, and growth. ... Comcast vs Netflix: Which Is the Better Dip Buy Now?

The energy sector is the top performer this year, but investors shouldn't forget the group's attractive dividend profile.

GCT's Q1 EPS jumps 53% and revenues hit $359.5M: a $365M-$390M Q2 outlook and new partnerships fuel momentum.

BTG Q1 earnings more than double and revenues jump 118% y/y on strong gold output, higher prices and robust sales volumes.

Can GS extend its 58.4% rally as IB rebounds, AI initiatives expand and strategic streamlining drives growth? Let us find out.

GE stock surges on strong aerospace demand and major engine deals, but high debt, rising costs and rich valuation may limit upside.

The S&P 500 is up by a modest amount, but if it keeps pace it will mark its 16th record close of 2026. The index tracking 500 of the largest U.S. publicly traded companies was up 0.2%. Oil prices are rising after President Trump slammed Iran's response to a U.S. peace proposal.

Market Catalysts Host Julie Hyman and Yahoo Finance Senior Reporter Brooke DiPalma track several of the day's top trending stock tickers, including memory chip stocks Micron Technology (MU), Intel (INTC), and Qualcomm (QCOM) opening at record highs; shares of Moderna (MRNA) and Novavax (NVAX) reacting to concerns around the hantavirus; and Constellation Energy (CEG) affirming its full-year guidance after beating first quarter earnings estimates.

Tesla investors buying near today's $420 share price are getting a big bonus - the Optimus business for free.

Shares of Moderna (NASDAQ:MRNA) are up roughly 6% in Monday morning trading, changing hands near $57.52 after Friday’s close of $54.35. The intraday move extends what has already been a powerful 2026 run for the mRNA pioneer. The rally is outpacing fellow vaccine names Pfizer (NYSE:PFE), up 2% near $26.10, and Novavax (NASDAQ:NVAX), basically flat ... Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

After decades of consistent dividend increases, McDonald's and Clorox could soon be eligible for a highly coveted designation among dividend-paying stocks.

Constellation Energy (NASDAQ:CEG) reported stronger-than-expected first quarter 2026 results, topping Wall Street estimates on both revenue and adjusted earnings as the company benefited from expanded generation capacity and improved operational performance across its fleet. The company...

Bank of America (NYSE:BAC) analyst Matthew O’Neill raised his price target on Affirm to $88 from $82 on May 11, while reiterating a Buy rating. The analyst upgrade follows a “clean beat and raise” fiscal Q3 2026 report and frames the recent share dip as “a brief air pocket” ahead of the company’s investor forum. ... BofA Hikes Affirm Price Target to $88: Clean Beat and Raise Sets Up the May 12 Investor Day

NVIDIA Corporation (NASDAQ:NVDA) is one of the 9 Best American Semiconductor Stocks to Buy According to Analysts. On May 7, 2026, NVIDIA Corporation (NASDAQ:NVDA) and Iren announced a strategic partnership aimed at accelerating the deployment of next-generation AI infrastructure. Under the agreement, the companies plan to support the deployment of up to 5 gigawatts of […]